C4IMMUNOLOGY Trademark

Trademark Overview


On Thursday, October 24, 2024, a trademark application was filed for C4IMMUNOLOGY with the United States Patent and Trademark Office. The USPTO has given the C4IMMUNOLOGY trademark a serial number of 98818633. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 29, 2025. This trademark is owned by OncoC4, Inc.. The C4IMMUNOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
c4immunology

General Information


Serial Number98818633
Word MarkC4IMMUNOLOGY
Filing DateThursday, October 24, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, April 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkC FOUR IMMUNOLOGY
Pseudo MarkC FOR IMMUNOLOGY
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOncoC4, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Thursday, October 24, 2024NEW APPLICATION ENTERED
Thursday, April 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 25, 2025ASSIGNED TO EXAMINER
Tuesday, April 29, 2025NON-FINAL ACTION WRITTEN
Tuesday, April 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 29, 2025NON-FINAL ACTION E-MAILED